Novel anti-PD-1 antibodies not acting through PD-1/pdl-1 blockade that enhance tumor clearance.-MedSci.cn

Novel anti-PD-1 antibodies not acting through PD-1/pdl-1 blockade that enhance tumor clearance.

Fenwick, C; Loredo-Varela, JL; Joo, V; Pellaton, C; Farina, A; Rajah, N; Decaillon, T; Esteves-Leuenberger, L; Suffiotti, M; Ohmiti, K; Gottardo, R; Weissenhorn, W; Pantaleo, G

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):

科室
- - 订阅+
  - 更多科室
工具
服务